BiotechTube

AZD2115 + Placebo + Indacaterol + Indacaterol + Tiotropium

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

COPD

Conditions

COPD

Trial Timeline

Mar 1, 2012 → Oct 1, 2012

NCT ID
NCT01498081

About AZD2115 + Placebo + Indacaterol + Indacaterol + Tiotropium

AZD2115 + Placebo + Indacaterol + Indacaterol + Tiotropium is a phase 2 stage product being developed by AstraZeneca for COPD. The current trial status is completed. This product is registered under clinical trial identifier NCT01498081. Target conditions include COPD.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01498081Phase 2Completed

Competing Products

20 competing products in COPD

See all competitors
ProductCompanyStageHype Score
Sitafloxacin + Moxifloxacin HydrochlorideDaiichi SankyoApproved
85
Reldesemtiv + PlaceboAstellas PharmaPhase 2
52
Lysozyme hydrochloride + PlaceboEisaiApproved
85
Arformoterol (Brovana) + PlaceboSumitomo PharmaApproved
85
Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Salmeterol MDI + PlaceboSumitomo PharmaPhase 3
77
Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Placebo + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + PlaceboSumitomo PharmaPhase 2
52
Arformoterol tartrate inhalation solution + TiotropiumSumitomo PharmaApproved
85
Racemic formoterol + Arformoterol tartrate inhalation solution + Racemic formoterolSumitomo PharmaPhase 2
52
Levalbuterol HCl + Levalbuterol HCl + Albuterol Sulfate + PlaceboSumitomo PharmaPhase 3
77
Formoterol Turbuhaler + Budesonide/Formoterol Turbuhaler + Formoterol TurbuhalerAstraZenecaPhase 1
33
RoflumilastAstraZenecaPhase 2/3
65
Aclidinium bromide + PlaceboAstraZenecaPhase 3
77
RoflumilastAstraZenecaPre-clinical
23
Symbicort (budesonide/formoterol turbuhaler 320/9ug) + Spiriva (tiotropium bromide 18ug)AstraZenecaApproved
85
AZD7624 + Placebo to matchAstraZenecaPhase 1
33
Roflumilast + PlaceboAstraZenecaPhase 3
77
Aclidinium bromide 100 μg bid + Aclidinium bromide 200 μg bid + Aclidininum bromide 400 μg bid + Placebo + Formoterol 12 μg bidAstraZenecaPhase 2
52
ACL/FOR + PlaceboAstraZenecaApproved
85
TozorakimabAstraZenecaPhase 2
52
AZD1981 + PlaceboAstraZenecaPhase 2
52

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85